Gastric cancer surgery in cirrhotic patients: Result of gastrectomy with D2 lymph node dissection

Table 3 Factors associated with complications

Variables	Complication		P
	Absent (n, %)	Present (n, %)
Sex			0.351
Male	42 (57.5)	31 (42.5)
Female	15 (71.4)	6 (28.6)
Age (yr)			0.138
<55	34 (66.7)	17 (33.3)
≥55	23 (53.4)	20 (46.6)
Causes of cirrhosis			0.188
HBV-related	36 (69.2)	16 (30.8)
Alcohol	14 (46.7)	16 (53.3)
HCV-related	4 (50.0)	4 (50.0)
Cryptogenic	3 (75.0)	1 (25.0)
Anemia (<100 g/L)			0.37
Absent	46 (62.2)	28 (37.8)
Present	11 (55)	9 (45.0)
Thrombocytopenia (<105/U)			0.619
Absent	45 (62.5)	27 (37.5)
Present	12 (54.5)	10 (45.5)
Albumin (g/L)			0.386
≥36	38 (64.4)	21 (35.6)
<36	19 (54.3)	16 (45.7)
Aspartate aminotransferase (IU/L)			0.03
≤40	40 (70.2)	17 (29.8)
>40	17 (63)	20 (37.0)
Bilirubin (mg/dL)			0.819
≤1.4	40 (59.7)	27 (40.3)
>1.4	17 (63)	10 (37.0)
Prothrombin (%)			0.656
≥80	39 (62.9)	23 (37.1)
<80	18 (56.3)	14 (43.7)
Child–Pugh class			0.207
A	52 (63.4)	30 (36.6)
B or C	5 (41.7)	7 (58.3)
Transfusion			<0.001
No	46 (75.4)	15 (24.6)
Yes	11 (33.3)	22 (66.7)
Extent of gastric resection			0.45
Subtotal	46 (63)	27 (37.0)
Total	11 (52.4)	10 (47.6)
Stage			0.835
EGC	26 (61.9)	16 (38.1)
AGC	31 (59.6)	21 (40.4)
Prophylactic drainage			0.055
No	27 (73)	10 (27.0)
Yes	30 (52.6)	27 (47.4)